129 материалов по теме, собраны автоматически из проверенных источников
NCCN Announces Awards for Quality Improvement Initiatives for Metastatic Prostate Cancer (mPCA) | Newswise Newswise
The first patient gets Janux's new immune treatment in a prostate cancer trial. Stock Titan
Rewriting the Playbook: How Biomarker-Driven Therapy Is Transforming Metastatic Prostate Cancer Care Targeted Oncology
Making Treatment Decisions in Advanced Prostate Cancer medpagetoday.com
Combining the targeted therapy olaparib with an additional immunotherapy may improve immune response in a subgroup of patients with metastatic castration-resistant prostate cancer who responded poorly to initial treatment, according to a Northwestern Medicine study published in The Journal of Clinical Investigation.
Four Approvals Reflect Growth in Hormone-Sensitive Prostate Cancer Treatment Targeted Oncology
Hybrid Decentralized Trial Design Helps VA Reach More Prostate Cancer Patients U.S. Medicine
International trial supports new strategy against metastatic prostate cancer IDIBELL – Institut d'Investigació Biomèdica de Bellvitge
Long-Term Trial Supports Selective Use of Extended Pelvic Lymph Node Dissection in High-Grade Prostate Cancer The ASCO Post
Prostate Cancer: Exercise Program Reduces Treatment Side Effects healthline.com
Prostate Cancer Genomic Analysis Links Mutational Footprints to Clinical Outcomes Inside Precision Medicine
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients Cure Today
Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively little about why the disease develops or why some men live with it for years while it progresses aggressively in others.
Exercise and wellbeing programme reduces side effects of prostate cancer treatment, study finds The Pharmaceutical Journal
Approximately 40% of men with prostate cancer treated with concurrent androgen deprivation therapy and androgen receptor pathway inhibitors may develop metabolic syndrome within a year. A retrospective analysis of nearly 17,000 patients showed the first metabolic condition, usually hypertension, occurs within the…